MSD Animal Health has agreed to acquire Scan Aqua AS to enhance its product offerings in the European aquaculture industry.
Information on the Target
MSD Animal Health, a division of Merck & Co., has entered into an agreement to acquire Scan Aqua AS. Scan Aqua specializes in developing, registering, and marketing products tailored for the European aquaculture industry, primarily focusing on enhancing fish welfare and operational efficiency.
The company’s product offerings include essential solutions such as AQUI-S and Finquel. AQUI-S serves as a calming agent used during various processes, including treatment, transportation, and handling of species like salmon and rainbow trout. Finquel, an anesthetic, is widely utilized in fish farming, particularly during vaccinations and other procedures requiring complete anesthesia, like lice counting.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Norway
The aquaculture industry in Norway is one of the most developed globally, contributing significantly to the country's economy. With a robust regulatory framework and a strong emphasis on sustainability, Norwegian aqua
Similar Deals
MSD Animal Health
invested in
Scan Aqua AS
in
in a Other deal